Loading clinical trials...
Loading clinical trials...
Muscle Weakness Duration Post-injection of a Single Dose of Botulinum Toxin in the Masseter Muscle Bilaterally: a One-year Non-randomized Controlled Trial
Conditions
Interventions
Botulinum toxin type A
Locations
1
Sweden
Norrlands universitetssjukhus
Umeå, Västerbotten County, Sweden
Start Date
March 1, 2020
Primary Completion Date
January 10, 2022
Completion Date
March 14, 2022
Last Updated
May 3, 2023
NCT06878482
NCT06456827
NCT06934317
NCT07253337
NCT07295574
Lead Sponsor
Region Västerbotten
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions